Some stocks are growing profits at a rapid pace, up to 125% a year, yet their share prices have corrected sharply, falling 40% to 65% from recent highs. This disconnect between business performance and market sentiment could offer rare opportunities to invest in fundamentally strong companies at attractive valuations.
Each of the stocks in this list has delivered consistent profit growth of over 35% annually for the last three years, signaling strong operational performance. Despite this, they remain under pressure in the market, possibly overlooked or undervalued. In this article, we’ll take a closer look at five such high-growth stocks trading well below their peaks.
Waaree Renewables Technologies Ltd
- 3-Year Profit CAGR: 125%
- Stock Decline: Down 47% from its Peak
Waaree Renewable Technologies Ltd (WRTL), a subsidiary of Waaree Energies Ltd, plays a leading role in India’s renewable EPC (Engineering, Procurement, and Construction) sector. The company has successfully executed over 10,000 solar projects with a combined capacity of 600+ MW.
WRTL is backed by the Waaree Group, India’s largest solar module manufacturer, with a robust order book of 26.5 GW valued at approximately Rs 47,000 crore. The group exports solar products to 26 countries, has a 15 GW module and 5.4 GW cell manufacturing capacity, and operates through 400+ franchise partners across India. Despite its strong fundamentals, the stock is currently down 47 percent to Rs 1,112 from its peak high of Rs 2,074.95 hit on 29th September 2024
The company reported a revenue of Rs 1597 crore in FY25, up by 84.2 percent from its FY24 revenue of Rs 867 crore. Coming to its profitability, the company reported a net profit rise of 53.7 percent to Rs 229 crore in FY25 from Rs 149 crore in FY24. The stock has delivered an impressive 3-year net profit CAGR of 125 percent , highlighting its strong earnings growth despite the recent price correction.
Adani Green Energy Ltd
- 3-Year Profit CAGR: 60%
- Stock Decline: Down 51% from its Peak
Adani Green Energy Ltd (AGEL) is one of India’s largest renewable energy companies, operating under the Adani Group’s vision of a cleaner, greener future. With a total operational renewable portfolio of 14,242.9 MW, AGEL develops, owns, and operates utility-scale grid-connected solar and wind projects. The company supplies power to central and state government entities through 25-year Power Purchase Agreements (PPAs), ensuring long-term revenue visibility.
AGEL has built a strong presence across 12 Indian states, with 54 operational projects and 12 under construction. Known for high efficiency, it boasts 99.6 percent solar plant availability and an asset base of USD 2 billion. Despite its strong fundamentals, the stock is currently down 51 percent to Rs 1028 from its peak high of Rs 2,091.85, hit on 26th September 2024.
The company reported a revenue of Rs 11,212 crore in FY25, up by 21.6 percent from its FY24 revenue of Rs 9,220 crore. Coming to its profitability, the company reported a net profit rise of 58.8 percent to Rs 2,001 crore in FY25 from Rs 1,260 crore in FY24. The stock has delivered an impressive 3-year net profit CAGR of 59 percent, highlighting its strong earnings growth despite the recent price correction.
UCO Bank
- 3-Year Profit CAGR: 38%
- Stock Decline: Down 48% from its Peak
UCO Bank is one of the leading public sector banks and a Government of India undertaking, headquartered in Kolkata, with a wide presence through 3,305 domestic branches across the country. The bank offers a full suite of financial services, including Retail Banking, Corporate Banking, and Treasury Operations, catering to a broad customer base.
For FY25–26, UCO Bank has guided for Deposit Growth of 10–12 percent, Credit Growth of 12–14 percent, and CASA Growth of 8–10 percent, while maintaining a CASA ratio between 37–38 percent, signaling continued focus on stable, low-cost funding and loan book expansion. Despite its strong financial outlook, the stock is currently down 48 percent to Rs 31.7 from its peak high of Rs 60.64, hit on 29th July 2024.
The company reported a revenue of Rs 25,067 crore in FY25, up by 14.7 percent from its FY24 revenue of Rs 21,854 crore. Coming to its profitability, the company reported a net profit rise of 47.6 percent to Rs 2,468 crore in FY25 from Rs 1,672 crore in FY24. The stock has delivered an impressive 3-year net profit CAGR of 38 percent, highlighting its strong earnings growth despite the recent price correction.
IREDA
- 3-Year Profit CAGR: 39%
- Stock Decline: Down 45% from its Peak
Indian Renewable Energy Development Agency Ltd (IREDA) is a government-owned financial institution under the Ministry of New and Renewable Energy (MNRE), established to promote, develop, and finance projects in the renewable energy and energy efficiency sectors. Registered as a non-deposit-taking NBFC, the RBI has also classified IREDA as an Infrastructure Finance Company, and the Government of India awarded it Navratna status.
As of March 31, 2025, IREDA reported strong growth in its operations, with loan sanctions rising 27% to Rs 47,453 crore, disbursements up 20% to Rs 30,168 crore, and outstanding loans increasing 28 percent to Rs 76,282 crore year-on-year. Despite its robust financial performance, the stock is currently down 45 percent to Rs 157 from its peak high of Rs 283, hit on 23rd July 2024.
The company reported a revenue of Rs 6,742 crore in FY25, up by 35.8 percent from its FY24 revenue of Rs 4,965 crore. Coming to its profitability, the company reported a net profit rise of 35.7 percent to Rs 1,699 crore in FY25 from Rs 1,252 crore in FY24. The stock has delivered an impressive 3-year net profit CAGR of 39 percent, highlighting its strong earnings growth despite the recent price correction.
Natco Pharma
- 3-Year Profit CAGR: 123%
- Stock Decline: Down 40% from its Peak
Natco Pharma Ltd (NATCO) is a vertically integrated, R&D-driven pharmaceutical company focused on developing and manufacturing complex and niche products. Its business spans finished dosage formulations (FDFs), active pharmaceutical ingredients (APIs), and contract manufacturing. NATCO distributes its products across more than 50 countries, with key markets including the U.S., Europe, India, and various RoW (rest of the world) regions.
The company has also forayed into crop health sciences, leveraging its expertise in organic chemistry to diversify into the agrochemical sector. Despite its strong business fundamentals and global footprint, the stock is currently down 40 percent to Rs 1010 from its peak high of Rs 1638, which was reached on 12th September 2024.
The company reported a revenue of Rs 4,430 crore in FY25, up by 10.8 percent from its FY24 revenue of Rs 3,999 crore. Coming to its profitability, the company reported a net profit rise of 35.7 percent to Rs 1,883 crore in FY25 from Rs 1,388 crore in FY24. The stock has delivered an impressive 3-year net profit CAGR of 123 percent, highlighting its strong earnings growth despite the recent price correction.
Written By: Rohan Pandey
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
